Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors

References

• Cancer Tomorrow. 2024. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=11&single_unit=50000&years=2030&types=1.Accessed May 6, 2022.
   Google Scholar
• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primer. 2021;7(1):6.
   PubMed Web of Science ®Google Scholar
• Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of us cancer incidence and death to 2040. JAMA Network Open. 2021;4(4):e214708. doi:10.1001/jamanetworkopen.2021.4708
   PubMed Web of Science ®Google Scholar
• Labgaa I, Villanueva A, Dormond O, Demartines N, Melloul E. The role of liquid biopsy in hepatocellular carcinoma prognostication. Cancers. 2021;13(4):659. doi:10.3390/cancers13040659
   Web of Science ®Google Scholar
• Villanueva A, Hoshida Y, Battiston C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011;140(5):1501–1512.e2. doi:10.1053/j.gastro.2011.02.006
   PubMed Web of Science ®Google Scholar
• Labgaa I, Torrecilla S, Martinez-Quetglas I, Sia D. Genetics of hepatocellular carcinoma: risk stratification, clinical outcome, and implications for therapy. Dig Dis Interv. 2017;01(2):55–65. doi:10.1055/s-0037-1603577
   Google Scholar
• Eggel H. Uber das primare Carcinoma der Leber. Beitr Pathol Anat Allg Pathol. 1901;30:506–604.
   Google Scholar
• Martins-Filho SN, Alves VAF. The strengths and weaknesses of gross and histopathological evaluation in hepatocellular carcinoma: a brief review. Surg Exp Pathol. 2019;2(1):23. doi:10.1186/s42047-019-0047-6
   Google Scholar
• Liver Cancer Stages. 2023. Available from: https://www.cancer.org/cancer/liver-cancer/detection-diagnosis-staging/staging.html.Accessed April 24, 2023.
   Google Scholar
• Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–699. doi:10.1056/NEJM199603143341104
   PubMed Web of Science ®Google Scholar
• Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–338. doi:10.1055/s-2007-1007122
   PubMed Web of Science ®Google Scholar
• Kluger MD, Salceda JA, Laurent A, et al. Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis. J Hepatol. 2015;62(5):1131–1140. doi:10.1016/j.jhep.2014.12.018
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lei X, Xu L, Lv X, Xu M, Tang H. Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection. BMC Surg. 2022;22(1):233. doi:10.1186/s12893-022-01682-0
   Web of Science ®Google Scholar
• Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study From China. JAMA Surg. 2019;154(3):209–217. doi:10.1001/jamasurg.2018.4334
   PubMed Web of Science ®Google Scholar
• Welling TH, Eddinger K, Carrier K, et al. Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation. Liver Transplant. 2018;24(9):1233–1242. doi:10.1002/lt.25194
   Web of Science ®Google Scholar
• Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245(6):909–922. doi:10.1097/01.sla.0000254368.65878.da
   PubMed Web of Science ®Google Scholar
• Meng KW, Dong M, Zhang WG, Huang QX. Clinical characteristics and surgical prognosis of hepatocellular carcinoma with bile duct invasion. Gastroenterol Res Pract. 2014;2014:604971. doi:10.1155/2014/604971
   Web of Science ®Google Scholar
• Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002;20(6):1527–1536. doi:10.1200/JCO.2002.20.6.1527
   PubMed Web of Science ®Google Scholar
• Poon RTP, Fan ST. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am. 2003;12(1):35–50. doi:10.1016/S1055-3207(02)00086-8
   Google Scholar
• Liu W, Wang K, Bao Q, Sun Y, Xing BC. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma. World J Surg Oncol. 2016;14:62. doi:10.1186/s12957-016-0811-y
   Web of Science ®Google Scholar
• Roayaie S, Jibara G, Taouli B, Schwartz M. Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol. 2013;20(12):3754–3760. doi:10.1245/s10434-013-3074-7
   PubMed Web of Science ®Google Scholar
• Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery. 2000;127(6):603–608. doi:10.1067/msy.2000.105498
   PubMed Web of Science ®Google Scholar
• Lee YJ, Lee YR, Seo CG, et al. How should we assign large infiltrative hepatocellular carcinomas for staging? Cancers. 2020;12(9):2589. doi:10.3390/cancers12092589
   Web of Science ®Google Scholar
• D’Amico F, Schwartz M, Vitale A, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transplant. 2009;15(10):1278–1287. doi:10.1002/lt.21842
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Poon RT, Abdalla EK, et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg Chic Ill. 2005;140(5):450–457.
   PubMedGoogle Scholar
• DuPont-Bierre E, Compagnon P, Raoul JL, Fayet G, de Lajarte-Thirouard AS, Boudjema K. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg. 2005;201(5):663–670. doi:10.1016/j.jamcollsurg.2005.06.265
   PubMed Web of Science ®Google Scholar
• Choi GH, Park JY, Hwang HK, et al. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int. 2011;31(4):485–493. doi:10.1111/j.1478-3231.2010.02436.x
   Web of Science ®Google Scholar
• Shetty K, Timmins K, Brensinger C, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transplant. 2004;10(7):911–918. doi:10.1002/lt.20140
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191(4):389–394. doi:10.1016/S1072-7515(00)00688-8
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11(9):1086–1092. doi:10.1002/lt.20472
   PubMed Web of Science ®Google Scholar
• Esaki M, Shimada K, Sano T, Sakamoto Y, Kosuge T, Ojima H. Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus. J Surg Oncol. 2005;90(4):226–232. doi:10.1002/jso.20260
   Web of Science ®Google Scholar
• Okuda K, Peters RL, Simson IW. Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer. 1984;54(10):2165–2173. doi:10.1002/1097-0142(19841115)54:10<2165:AID-CNCR2820541017>3.0.CO;2-7
   Web of Science ®Google Scholar
• Sakon M, Monden M, Umeshita K, et al. The prognostic significance of macroscopic growth pattern of hepatocellular carcinoma. Int Surg. 1994;79(1):38–42.
   Web of Science ®Google Scholar
• The general rules for the clinical and pathological study of primary liver cancer. Liver cancer study group of Japan. Jpn J Surg. 1989;19(1):98–129. doi:10.1007/BF02471576
   Google Scholar
• Kudo M, Kitano M, Sakurai T, Nishida N. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the liver cancer study Group of Japan. Dig Dis. 2015;33(6):765–770. doi:10.1159/000439101
   PubMed Web of Science ®Google Scholar
• Jang JY, Lee JS, Kim HJ, et al. The General rules for the study of primary liver cancer. J Liver Cancer. 2017;17(1):19–44. doi:10.17998/jlc.17.1.19
   Google Scholar
• Hui AM, Takayama T, Sano K, et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol. 2000;33(6):975–979. doi:10.1016/S0168-8278(00)80131-2
   Web of Science ®Google Scholar
• Rhee H, Chung T, Yoo JE, et al. Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression. Hepatol Int. 2020;14(2):239–248. doi:10.1007/s12072-020-10012-6
   Web of Science ®Google Scholar
• He J, Shi J, Fu X, et al. The clinicopathologic and prognostic significance of gross classification on solitary hepatocellular carcinoma after hepatectomy. Medicine. 2015;94(32):e1331. doi:10.1097/MD.0000000000001331
   Web of Science ®Google Scholar
• Lee Y, Park H, Lee H, et al. The clinicopathological and prognostic significance of the gross classification of hepatocellular carcinoma. J Pathol Transl Med. 2018;52(2):85–92. doi:10.4132/jptm.2017.11.13
   Google Scholar
• Choi GH, Han DH, Kim DH, et al. Outcome after curative resection for a huge (≥10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg. 2009;198(5):693–701. doi:10.1016/j.amjsurg.2008.09.019
   PubMed Web of Science ®Google Scholar
• Hatanaka K, Minami Y, Kudo M, Inoue T, Chung H, Haji S. The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US. J Clin Ultrasound. 2014;42(1):1–8. doi:10.1002/jcu.22080
   Web of Science ®Google Scholar
• Chau GY, Lui WY, Tsay SH, et al. Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs’ A patients. J Surg Oncol. 1997;66(2):122–126. doi:10.1002/(SICI)1096-9098(199710)66:2<122:AID-JSO9>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Park YK, Kim BW, Wang HJ, Kim MW. Hepatic resection for hepatocellular carcinoma meeting Milan criteria in child-Turcotte-Pugh class a patients with cirrhosis. Transplant Proc. 2009;41(5):1691–1697. doi:10.1016/j.transproceed.2008.07.146
   Web of Science ®Google Scholar
• Kondo K, Chijiiwa K, Makino I, et al. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2005;12(5):399–404. doi:10.1007/s00534-005-1009-9
   Google Scholar
• Li L, Xu L, Zhou S, Wang P, Zhang M, Li B. Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis. BMC Surg. 2022;22(1):104. doi:10.1186/s12893-022-01564-5
   Web of Science ®Google Scholar
• College of American Pathologists. Protocol for the examination of specimens from patients with hepatocellular carcinoma; 2023. Available from: https://documents.cap.org/protocols/Liver.HCC_4.2.0.0.REL_CAPCP.pdf.Accessed April 24, 2023.
   Google Scholar
• Fan Z, Jin M, Zhang L, et al. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification. Gut. 2023;2023:1.
   Google Scholar
• Su K, Huang W, Li X, et al. Evaluation of lactate dehydrogenase and alkaline phosphatase as predictive biomarkers in the prognosis of hepatocellular carcinoma and development of a new nomogram. J Hepatocell Carcinoma. 2023;10:69–79. doi:10.2147/JHC.S398632
   PubMed Web of Science ®Google Scholar
• Su K, Shen Q, Tong J, et al. Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: a large, multicenter study. Ann Hepatol. 2023;28(4):101109. doi:10.1016/j.aohep.2023.101109
   PubMed Web of Science ®Google Scholar
• Li H, Guo L, Su K, et al. Construction and validation of TACE therapeutic efficacy by ALR score and nomogram: a large, multicenter Study. J Hepatocell Carcinoma. 2023;10:1009–1017. doi:10.2147/JHC.S414926
   PubMed Web of Science ®Google Scholar
• Burt AD, Alves V, Bedossa P, et al. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer reporting (ICCR). Histopathology. 2018;73(3):369–385. doi:10.1111/his.13520
   PubMed Web of Science ®Google Scholar
• Gao Q, Zhu H, Dong L, et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell. 2019;179(2):561–577.e22. doi:10.1016/j.cell.2019.08.052
   PubMed Web of Science ®Google Scholar
• Amaddeo G, Cao Q, Ladeiro Y, et al. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas. Gut. 2015;64(5):820–829. doi:10.1136/gutjnl-2013-306228
   PubMed Web of Science ®Google Scholar
• Pelizzaro F, Trevisani F, Simeon V, et al. Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection. Liver Int. 2023;43(12):2762–2775. doi:10.1111/liv.15719
   PubMed Web of Science ®Google Scholar
• Pinyol R, Montal R, Bassaganyas L, et al. Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the Phase 3 STORM trial. Gut. 2019;68(6):1065–1075. doi:10.1136/gutjnl-2018-316408
   PubMed Web of Science ®Google Scholar
• Montironi C, Castet F, Haber PK, et al. Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. Gut. 2023;72(1):129–140. doi:10.1136/gutjnl-2021-325918
   PubMed Web of Science ®Google Scholar
• Zeng Q, Klein C, Caruso S, et al. Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology. J Hepatol. 2022;77(1):116–127. doi:10.1016/j.jhep.2022.01.018
   PubMed Web of Science ®Google Scholar
• Schmauch B, Romagnoni A, Pronier E, et al. A deep learning model to predict RNA-Seq expression of tumours from whole slide images. Nat Commun. 2020;11(1):3877. doi:10.1038/s41467-020-17678-4
   PubMed Web of Science ®Google Scholar
• Calderaro J, Seraphin TP, Luedde T, Simon TG. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. J Hepatol. 2022;76(6):1348–1361. doi:10.1016/j.jhep.2022.01.014
   PubMed Web of Science ®Google Scholar
• Su K, Wang F, Li X, et al. Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period. Front Immunol. 2023;14:1265959. doi:10.3389/fimmu.2023.1265959
   Web of Science ®Google Scholar
• Li H, Wu Z, Chen J, et al. External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Clin Exp Med. 2023;23(5):1537–1549. doi:10.1007/s10238-022-00972-4
   Web of Science ®Google Scholar
• Li H, Su K, Guo L, et al. PD-1 inhibitors combined with antiangiogenic therapy with or without transarterial chemoembolization in the treatment of hepatocellular carcinoma: a propensity matching analysis. J Hepatocell Carcinoma. 2023;10:1257–1266. doi:10.2147/JHC.S415843
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi:10.1016/j.jhep.2021.11.018
   PubMed Web of Science ®Google Scholar
• Hack SP, Spahn J, Chen M, et al. IMbrave 050: a of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation. Future Oncol. 2020;16(15):975–989. doi:10.2217/fon-2020-0162
   PubMed Web of Science ®Google Scholar
• Jung S-M, Kim JM, Choi G-S, et al. Characteristics of early recurrence after curative liver resection for solitary hepatocellular carcinoma. J Gastrointest Surg. 2019;23:304–311.
   PubMed Web of Science ®Google Scholar
• Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl. 2004;10:534–540. doi:10.1002/lt.20128
   PubMed Web of Science ®Google Scholar
• Parfitt JR, Marotta P, Alghamdi M, et al. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl. 2007;13:543–551. doi:10.1002/lt.21078
   PubMed Web of Science ®Google Scholar
• Ochiai T, Ikoma H, Okamoto K, Kokuba Y, Sonoyama T, Otsuji E. Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection. World J Surg. 2012;36:136–143. doi:10.1007/s00268-011-1317-y
   PubMed Web of Science ®Google Scholar
• Shah SA, Tan JCC, McGilvray ID, et al. Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J Gastrointest Surg. 2007;11:464–471. doi:10.1007/s11605-006-0033-7
   Web of Science ®Google Scholar
• Yamamoto Y, et al. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2015;21(1):246–253. doi:10.3748/wjg.v21.i1.246
   Web of Science ®Google Scholar
• Du Z-G, Wei Y-G, Chen K-F, Li B. Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution’s experience with 398 consecutive patients. Hepatobiliary Pancreat Dis Int. 2014;13(2):153–161. doi:10.1016/S1499-3872(14)60025-4
   PubMed Web of Science ®Google Scholar
• Goh BKP, Teo J-Y, Chan C-Y, et al. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: implications on the current AJCC staging system. J Surg Oncol. 2016;113(1):89–93. doi:10.1002/jso.24099
   PubMed Web of Science ®Google Scholar
• Oba A, Takahashi S, Kato Y, et al. Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus. Anticancer Res. 2014;34(8):4367–4372.
   Web of Science ®Google Scholar
• Lin S-H, Eng H-L, Liu Y-W, et al. Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection. Am J Surg. 2022;223(2):339–345. doi:10.1016/j.amjsurg.2021.03.065
   Web of Science ®Google Scholar
• Zavaglia C, De Carlis L, Alberti AB, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol. 2005;100(12):2708–2716. doi:10.1111/j.1572-0241.2005.00289.x
   PubMed Web of Science ®Google Scholar
• Zhang H, Yuan S-X, Dai S-Y, et al. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion. World J Surg. 2014;38(4):947–957. doi:10.1007/s00268-013-2365-2
   PubMed Web of Science ®Google Scholar
• Lim C, Mise Y, Sakamoto Y, et al. Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma. World JSurg. 2014;38(11):2910–2918. doi:10.1007/s00268-014-2704-y
   Web of Science ®Google Scholar
• Silva JPM, Coelho FF, Cassenote AJF, et al. Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral center. BMC Surg. 2022;22(1):329. doi:10.1186/s12893-022-01779-6
   Web of Science ®Google Scholar
• Shimada M, Rikimaru T, Hamatsu T, et al. The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg. 2001;182(2):177–182. doi:10.1016/S0002-9610(01)00682-1
   PubMed Web of Science ®Google Scholar